• Type: Research compound (small molecule, not a peptide)

• Research area: Localized adipose-tissue reduction

• Form: Lyophilized powder (reconstitute as directed by the COA)

• Purity: ≥ 99%, COA per batch

• Storage: Refrigerate (2 to 8 °C) after reconstitution

Overview

CBL-514 is a research compound (a small molecule, not a peptide) studied in models of localized adipose-tissue reduction.

Technical details

An injectable compound investigated for inducing adipocyte apoptosis in studies (localized lipolysis). Not a peptide.

What sets it apart

• A specific research mechanism (adipocyte apoptosis), distinct from the peptides.

• A compound in clinical development and a focus of scientific interest.

• Purity ≥ 99% with a COA per batch.

Handling & warnings

• Experimental compound, for research use only.

• Reconstitute as directed by the COA, using sterile technique.

• Keep refrigerated (2 to 8 °C) after reconstitution.

FAQ

• Is CBL-514 lyophilized? Yes, it ships as a lyophilized powder and must be reconstituted.

• Is it a peptide? No. It is a small molecule (research compound).

• How should I store it? Cool and dry while sealed; refrigerated (2 to 8 °C) once reconstituted.

• What is the purity? Is there a COA? ≥ 99%, with a COA per batch.

• What does it study? In research, it is investigated in localized fat reduction through adipocyte apoptosis.